DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome

Overview of attention for article published in Frontiers in Behavioral Neuroscience, June 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 3 X users

patent: 2 patents

Citations

dimensions_citation: 142 Dimensions

Readers on

mendeley: 180 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 191,400 followers.

@deNutrients @brienblatt Please message me your email and I'll send a zip file with all sorts of research on DYRK1a and its link to autism and other neuro disorders. You would be very interested. Harmine happens to be the most potent inhibitor available to

04 Dec 2018

Reply Repost Favourite

PubMed: DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development… https://t.co/RtcKWXaJhL

06 Jul 2016

Reply Repost Favourite

DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in... https://t.co/kdlrNFIKNc

03 Jun 2016

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.